We are live on ! Find out more
CI

Clal Insurance Portfolio holdings

AUM $16.6B
1-Year Est. Return 68.34%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+68.34%
3 Year Est. Return
+151.82%
5 Year Est. Return
+175.48%
10 Year Est. Return
+729.64%
AUM
$3.8B
AUM Growth
-$343M
Cap. Flow
-$601M
Cap. Flow %
-15.81%
Top 10 Hldgs %
64.95%
Holding
74
New
9
Increased
20
Reduced
16
Closed
9

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$96.4M
2
ORBK
Orbotech Ltd
ORBK
+$95.9M
3
DOX icon
Amdocs
DOX
+$37.4M
4
ORA icon
Ormat Technologies
ORA
+$27.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 12.87%
2 Financials 7.47%
3 Healthcare 5.99%
4 Communication Services 5.59%
5 Industrials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICL icon
51
ICL Group
ICL
$6.62B
$2.63M 0.07%
649,982
HEWJ icon
52
iShares Currency Hedged MSCI Japan ETF
HEWJ
$721M
$2.57M 0.07%
76,722
-4,043,766
-98% -$132M
DGRE icon
53
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$137M
$2.5M 0.07%
91,940
IEO icon
54
iShares US Oil & Gas Exploration & Production ETF
IEO
$565M
$2.08M 0.05%
31,973
-1,168,027
-97% -$70.6M
CEL
55
DELISTED
Cellcom Israel, Ltd.
CEL
$2.02M 0.05%
197,526
EVGN icon
56
Evogene
EVGN
$5.81M
$1.84M 0.05%
59,998
FEZ icon
57
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.32B
$1.74M 0.05%
42,691
CVX icon
58
Chevron
CVX
$380B
$1.69M 0.04%
13,460
PANW icon
59
Palo Alto Networks
PANW
$258B
$395K 0.01%
+16,332
New +$397K
URGN icon
60
UroGen Pharma
URGN
$2B
$166K ﹤0.01%
+4,461
New +$159K
XRT icon
61
State Street SPDR S&P Retail ETF
XRT
$461M
$155K ﹤0.01%
3,440
SEDG icon
62
SolarEdge
SEDG
$2.48B
$102K ﹤0.01%
+2,723
New +$93.8K
PJT icon
63
PJT Partners
PJT
$4.3B
$36K ﹤0.01%
782
AAPL icon
64
Apple
AAPL
$5.02T
-46,800
Closed -$1.8M
ACWI icon
65
iShares MSCI ACWI ETF
ACWI
$32.3B
-220
Closed -$15K
IWM icon
66
iShares Russell 2000 ETF
IWM
$79.8B
-694,088
Closed -$103M
RDWR icon
67
Radware
RDWR
$1.01B
-221,790
Closed -$3.74M
TBF icon
68
ProShares Short 20+ Year Treasury ETF
TBF
$86.7M
-11,189
Closed -$251K
UBS icon
69
UBS Group
UBS
$171B
$0 ﹤0.01%
+1
New +$17
RSX
70
DELISTED
VanEck Russia ETF
RSX
-2,941,327
Closed -$65.6M

Similar funds

Clal Insurance's Q4 2017 Portfolio in Review

As of Q4 2017, Clal Insurance held 74 positions worth $3.8B, down 8.3% from $4.14B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Clal Insurance withdrew a net $601M in Q4 2017, closing 9 positions and reducing 16 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Clal Insurance opened a new position in Amdocs worth $37.8M.

  • Clal Insurance's largest Q4 2017 buy was Amdocs: 575,727 shares worth $37.8M.
  • Clal Insurance added most to Perrigo in Q4 2017, an estimated $96.4M increase.
  • Clal Insurance's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $201M.
  • Clal Insurance fully exited iShares Russell 2000 ETF in Q4 2017, selling an estimated $103M.
  • Clal Insurance's ten largest holdings make up 65% of its $3.8B portfolio in Q4 2017.
  • Clal Insurance opened 9 new positions and closed 9 in Q4 2017.
  • Clal Insurance's portfolio value fell 8.3% quarter-over-quarter to $3.8B.

Based on Clal Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.